Cochlear Stock Book Value Per Share
| COH Stock | 293.44 2.18 0.74% |
Cochlear fundamentals help investors to digest information that contributes to Cochlear's financial success or failures. It also enables traders to predict the movement of Cochlear Stock. The fundamental analysis module provides a way to measure Cochlear's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cochlear stock.
Cochlear | Book Value Per Share |
Cochlear Company Book Value Per Share Analysis
Cochlear's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Cochlear Book Value Per Share | 28.10 X |
Most of Cochlear's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cochlear is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
Cochlear Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, the book value per share of Cochlear is about 28.102 times. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The book value per share for all Australia stocks is notably lower than that of the firm.
Cochlear Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Cochlear's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Cochlear could also be used in its relative valuation, which is a method of valuing Cochlear by comparing valuation metrics of similar companies.Cochlear is currently under evaluation in book value per share category among its peers.
Cochlear ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Cochlear's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Cochlear's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Cochlear Fundamentals
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.12 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 19.46 B | ||||
| Shares Outstanding | 65.43 M | ||||
| Shares Owned By Insiders | 0.51 % | ||||
| Shares Owned By Institutions | 48.57 % | ||||
| Price To Book | 10.51 X | ||||
| Price To Sales | 8.76 X | ||||
| Revenue | 2.26 B | ||||
| Gross Profit | 1.45 B | ||||
| EBITDA | 578.9 M | ||||
| Net Income | 356.8 M | ||||
| Cash And Equivalents | 555.5 M | ||||
| Total Debt | 243.7 M | ||||
| Book Value Per Share | 28.10 X | ||||
| Cash Flow From Operations | 388.8 M | ||||
| Earnings Per Share | 5.44 X | ||||
| Target Price | 294.95 | ||||
| Number Of Employees | 5 K | ||||
| Beta | 0.46 | ||||
| Market Capitalization | 19.59 B | ||||
| Total Asset | 2.75 B | ||||
| Retained Earnings | 667.9 M | ||||
| Working Capital | 820.6 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.75 B | ||||
| Last Dividend Paid | 4.1 |
About Cochlear Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cochlear's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cochlear using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cochlear based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cochlear Stock Analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.